MiR-761 promotes progression and metastasis of non-small cell lung cancer by targeting ING4 and TIMP2

Cellular Physiology and Biochemistry

Volumn 37, Issue 1, 2015, Pages 55-66

  Yan, An ^a   Yang, Chunyu ^a   Chen, Zhibo ^a   Li, Chunhong ^a   Cai, Li ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

ING4; Metastasis; MiR 761; NSCLC; Proliferation; TIMP2

Indexed keywords

INHIBITOR OF GROWTH FAMILY MEMBER 4; MICRORNA; MICRORNA 761; PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; HOMEODOMAIN PROTEIN; ING4 PROTEIN, HUMAN; TIMP2 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ADULT; ARTICLE; CANCER GENETICS; CANCER GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC REGULATION; GROWTH REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CARCINOGENESIS; MALE; METASTASIS; MOLECULAR PATHOLOGY; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; PROTEIN RNA BINDING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; CELL LINE; CELL PROLIFERATION; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; MIDDLE AGED; PATHOLOGY; TUMOR CELL LINE;

CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE PROTEINS; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM METASTASIS; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 84939560675     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000430333     Document Type: Article

References (31)

1. Ettinger DS, Akerley W, Borghaei H, Chang AC, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Ganti AK, Govindan R, Grannis FW, Jr., Horn L, Jahan TM, Jahanzeb M, Kessinger A, Komaki R, Kong FM, Kris MG, Krug LM, Lennes IT, Loo BW, Jr., Martins R, O'Malley J, Osarogiagbon RU, Otterson GA, Patel JD, Pinder-Schenck MC, Pisters KM, Reckamp K, Riely GJ, Rohren E, Swanson SJ, Wood DE, Yang SC, Hughes M, Gregory KM: Non-small cell lung cancer. J Natl Compr Canc Netw 2012;10:1236-1271
2. Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA: Non-small cell lung cancer: Epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 2008;83:584-594
3. Peters S, Adjei AA, Gridelli C, Reck M, Kerr K, Felip E, Group EGW: Metastatic non-small-cell lung cancer (nsclc): Esmo clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012;23:vii56-64
4. Rusch VW, Asamura H, Watanabe H, Giroux DJ, Rami-Porta R, Goldstraw P, Members of ISC: The iaslc lung cancer staging project: A proposal for a new international lymph node map in the forthcoming seventh edition of the tnm classification for lung cancer. J Thorac Oncol 2009;4:568-577
5. Beckles MA, Spiro SG, Colice GL, Rudd RM: Initial evaluation of the patient with lung cancer: Symptoms, signs, laboratory tests, and paraneoplastic syndromes. Chest 2003;123:97S-104S
6. Cornfield J, Haenszel W, Hammond EC, Lilienfeld AM, Shimkin MB, Wynder EL: Smoking and lung cancer: Recent evidence and a discussion of some questions. 1959. Int J Epidemiol 2009;38:1175-1191
7. Toh CK, Gao F, Lim WT, Leong SS, Fong KW, Yap SP, Hsu AA, Eng P, Koong HN, Thirugnanam A, Tan EH: Never-smokers with lung cancer: Epidemiologic evidence of a distinct disease entity. J Clin Oncol 2006;24:2245-2251
8. Stefani G, Slack FJ: Small non-coding rnas in animal development. Nat Rev Mol Cell Biol 2008;9:219-230
9. Hu X, Zhang F, Liu XR, Wu YT, Ni YM: Efficacy and potential microrna mechanism for computed tomography-guided percutaneous radiofrequency ablation of primary lung cancer and lung metastasis from liver cancer. Cell Physiol Biochem 2014;33:1261-1271
10. Zhang H, Zhao M, Lv Z, Zhang X, Qin X, Wang H, Wang S, Su J, Lv X, Liu H, Du W, Zhou W, Chen X, Fei K: Mir-138 inhibits tumor growth through repression of ezh2 in non-small cell lung cancer. Cell Physiol Biochem 2013;31:56-65
11. Wang J, Yang B, Han L, Li X, Tao H, Zhang S, Hu Y: Demethylation of mir-9-3 and mir-193a genes suppresses proliferation and promotes apoptosis in non-small cell lung cancer cell lines. Cell Physiol Biochem 2013;32:1707-1719
12. Guz M, Rivero-Muller A, Okon E, Stenzel-Bembenek A, Polberg K, Slomka M, Stepulak A: Micrornas-role in lung cancer. Dis Markers 2014;2014:218169
13. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, Harris CC: Unique microrna molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006;9:189-198
14. Long B, Wang K, Li N, Murtaza I, Xiao JY, Fan YY, Liu CY, Li WH, Cheng Z, Li P: Mir-761 regulates the mitochondrial network by targeting mitochondrial fission factor. Free Radic Biol Med 2013;65:371-379
15. Cohen JE, Lee PR, Fields RD: Systematic identification of 3'-utr regulatory elements in activity-dependent mrna stability in hippocampal neurons. Philos Trans R Soc Lond B Biol Sci 2014;369
16. Xia Y, Chen Q, Zhong Z, Xu C, Wu C, Liu B, Chen Y: Down-regulation of mir-30c promotes the invasion of non-small cell lung cancer by targeting mta1. Cell Physiol Biochem 2013;32:476-485
17. Raponi M, Dossey L, Jatkoe T, Wu X, Chen G, Fan H, Beer DG: Microrna classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res 2009;69:5776-5783
18. Xie Y, Zhang H, Sheng W, Xiang J, Ye Z, Yang J: Adenovirus-mediated ing4 expression suppresses lung carcinoma cell growth via induction of cell cycle alteration and apoptosis and inhibition of tumor invasion and angiogenesis. Cancer Lett 2008;271:105-116
19. Bourboulia D, Han H, Jensen-Taubman S, Gavil N, Isaac B, Wei B, Neckers L, Stetler-Stevenson WG: Timp-2 modulates cancer cell transcriptional profile and enhances e-cadherin/beta-catenin complex expression in a549 lung cancer cells. Oncotarget 2013;4:166-176
20. Siegel R, Ma J, Zou Z, Jemal A: Cancer statistics, 2014. CA Cancer J Clin 2014;64:9-29
21. Lag R, Eisner M, Kosary C, Hankey BF, Miller BA, Clegg L, Edwards BK (eds): Cancer statistics review, 1975-2002. Bethesda, MD: National Cancer Institute 2005;2005
22. Chiramannil A: Clinical snapshot: lung cancer. Am J Nurs 1998;98:46-47
23. Roberts PF, Straznicka M, Lara PN, Lau DH, Follette DM, Gandara DR, Benfield JR: Resection of multifocal non-small cell lung cancer when the bronchioloalveolar subtype is involved. J Thorac Cardiovasc Surg 2003;126:1597-1601
24. Iniesta P, Moran A, De Juan C, Gomez A, Hernando F, Garcia-Aranda C, Frias C, Diaz-Lopez A, Rodriguez-Jimenez FJ, Balibrea JL, Benito M: Biological and clinical significance of mmp-2, mmp-9, timp-1 and timp-2 in non-small cell lung cancer. Oncol Rep 2007;17:217-223
25. Lewis BP, Burge CB, Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microrna targets. Cell 2005;120:15-20
26. Kim S, Chin K, Gray JW, Bishop JM: A screen for genes that suppress loss of contact inhibition: Identification of ing4 as a candidate tumor suppressor gene in human cancer. Proc Natl Acad Sci U S A 2004;101:16251-16256
27. Garkavtsev I, Kozin SV, Chernova O, Xu L, Winkler F, Brown E, Barnett GH, Jain RK: The candidate tumour suppressor protein ing4 regulates brain tumour growth and angiogenesis. Nature 2004;428:328-332
28. Wang QS, Li M, Zhang LY, Jin Y, Tong DD, Yu Y, Bai J, Huang Q, Liu FL, Liu A, Lee KY, Fu SB: Down-regulation of ing4 is associated with initiation and progression of lung cancer. Histopathology 2010;57:271-281
29. Doyon Y, Cayrou C, Ullah M, Landry AJ, Cote V, Selleck W, Lane WS, Tan S, Yang XJ, Cote J: Ing tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation. Mol Cell 2006;21:51-64
30. Ling C, Xie Y, Zhao D, Zhu Y, Xiang J, Yang J: Enhanced radiosensitivity of non-small-cell lung cancer (nsclc) by adenovirus-mediated ing4 gene therapy. Cancer Gene Ther 2012;19:697-706
31. Wang R, Huang J, Feng B, De W, Chen L: Identification of ing4 (inhibitor of growth 4) as a modulator of docetaxel sensitivity in human lung adenocarcinoma. Mol Med 2012;18:874-886